<DOC>
	<DOCNO>NCT00751829</DOCNO>
	<brief_summary>To evaluate efficacy long-term treatment individually optimized dos olmesartan medoxomil compare nitrendipine elderly elderly patient isolate systolic hypertension . The study hypothesis non-inferiority olmesartan medoxomil compare nitrendipine lower mean sit systolic blood pressure 12 week treatment compare baseline . The study duration 32 week , include 24-week treatment period . After 12 week hydrochlorothiazide may add control blood pressure . Efficacy safety measurement carry 15 visit trial period .</brief_summary>
	<brief_title>Isolated Systolic Hypertension Elderly Very Elderly</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Olmesartan</mesh_term>
	<mesh_term>Olmesartan Medoxomil</mesh_term>
	<mesh_term>Hydrochlorothiazide</mesh_term>
	<mesh_term>Nitrendipine</mesh_term>
	<criteria>Age 65 old Mean sit BP &gt; 160 mmHg mean sit dBP &lt; 90 mmHg Secondary hypertension Malignant hypertension Severe Heart Failure ( NYHA IIIIV ) Recent history myocardial infarction Hypersensitivity study medication History drug alcohol abuse History evidence renal disease</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2008</verification_date>
</DOC>